
MEP Vytenis Andriukaitis Highlights the Importance of Europe’s Biotech Future and Patient Access
In a video message to EAPM’s Dublin conference, the MEP and rapporteur for the Biotech Act underlined the importance of translating Europe’s scientific and technological potential into tangible benefits for patients. European biotechnology is entering a pivotal phase, with the EU seeking to strengthen its innovation ecosystem while ensuring that
